In combination with highly compliant manual disinfection that included the use of surface disinfectant wipes, the CDC-funded Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study showed Tru-D was able to reduce the relative risk of colonization and infection among patients in hospital settings.
PDI Products on List N: Disinfectants for Use Against SARS-CoV-2
On March 13, 2020, the CDC updated their recommendations to refer to List N on the EPA website for EPA-registered disinfectants that have qualified under EPA’s emerging viral pathogens program for use against SARS-CoV-2.
We continue to closely monitor the COVID-19 pandemic (SARS-CoV-2) and its impact on both our customers and our regular business operations. Our number one priority is the protection of patients, caregivers, families and our employees. Understanding the urgency around preparing for this pandemic in the United States, we have implemented the following measures.